Alivus Life Sciences Limited — Others, 08-05-2025: Trading Window

Alivus Life Sciences Limited has announced a board meeting to approve the financial results for the quarter and year ended March 31, 2025, and to consider a dividend for the year. The company has also notified designated persons about the trading window closure from March 31 to May 17, 2025, aligning with its insider trading policies. This signals upcoming key financial disclosures and possible shareholder returns.